22157.jpg
Worldwide Glycobiology Industry to 2025 - Impact Analysis of COVID-19
November 11, 2020 06:23 ET | Research and Markets
Dublin, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The "Global Glycobiology Market By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate kinases,...
22157.jpg
Global Kinase Inhibitors Markets 2019-2020 & 2027 - Surge in Product Approvals & Increase in Incident of Cancer Diseases
September 09, 2020 06:58 ET | Research and Markets
Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Kinase Inhibitors - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Kinase Inhibitors...
MolecularMD Corp. Obtains Exclusive License to LKB1 Uses in Non-Small Cell Lung Cancer
January 28, 2013 08:30 ET | MolecularMD
PORTLAND, OR--(Marketwire - Jan 28, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...